A randomised, double-blind, placebo-controlled study was conducted among 56 day-case patients to determine the effect of the preoperative administration of rectal indomethacin on postoperative pain and opioid requirements after laparoscopic sterilisation. Outcome in women receiving indomethacin did not differ significantly from the placebo group, but there was a trend to lower subjective pain scores, reduction in early postoperative pain assessed objectively and lower parenteral pethidine requirements in the first three hours postoperatively. Indomethacin did not appear either to cause side-effects or to significantly reduce morbidity from the other postoperative sequelae of laparoscopy. Despite evidence for postoperative analgesic effect, the clinical benefits of premedication with rectal indomethacin were minor.
Laparoscopic sterilisation is the most common method of female sterilisation used in the Western world today. It is usually performed on a day-stay basis and consequently measures which reduce postoperative morbidity are to be welcomed.
It has been suggested that prostaglandins play a significant role in the genesis of abdominal pain after laparoscopic sterilisation. I Anecdotal reports and a preliminary investigation at this hospital have suggested a reduction in patient discomfort postoperatively in those patients premedicated with a prostaglandin synthetase inhibitor.
This study was designed to determine if preoperative indomethacin offered any benefit with respect to reduction of postoperative pain and morbidity.
MATERIALS AND METHODS· Approval for the study was obtained from the hospital Research Advisory and Ethics Committee and written informed consent obtained from each patient.
Women invited to participate in the study were 18-45 years of age, 40 to 100 kg and scheduled for elective laparoscopic sterilisation with or without uterine currettage. Exclusion criteria included those using or allergic to nonsteroidal anti inflammatory drugs (NSAIDs) or aspirin and those with serious hepatic, renal or gastrointestinal disease, or a bleeding disorder.
Patients were randomised into two groups to receive either two 100 mg indomethacin (Indocid, Mercke Sharp and Dohme) suppositories (Group I), or two identical placebo suppositories (Group 2) prepared by the hospital pharmacy in coded bottles so that staff were blind to the actual preparation.
Anaesthesia was standardised for all patients, each receiving a premedication of temazepam 10 mg orally at the same time as the suppositories, two hours preoperatively. General anaesthesia consisted of droperidol 1.25 mg IV, fentanyl 1.5 mcg/kg IV, propofol 2 mg/kg, followed by maintenance with nitrous oxide and enflurane as required. Intubation and muscle paralysis were accomplished with either suxamethonium, vecuronium or both.
The operative procedure itself was standardised with a routine subumbilical and suprapubic incision. Filshie clips were used exclusively and the abdomen was evacuated of carbon dioxide prior to termination of the procedure.
The quality of analgesia on arousal immediately postoperatively was assessed by the nursing staff in the recovery room using a four-point pain-grading (0 = no pain, 1 = minimal pain, 2 = moderate pain, 3 = severe pain). Upon further recovery, patients were asked to complete a 100 mm visual linear analogue pain scale (at 30 minutes, one and three hours postoperatively). Analgesic requirements were met by the attending anaesthetist using 25 mg aliquots of pethidine intravenously in the recovery room till comfortable, and on the ward by the sister responsible, using 1.0 mg/kg of intramuscular pethidine, two-hourly if requested. Total dosage was summated following discharge. Patient characteristics of age, weight, duration of operative procedure and duration from premedication to first recovery assessment were documented, as was the presence of various syptoms both pre-and postoperatively ( Table 2) . Demographic data and pethidine dosage were described using mean ± standard deviation (SO).
Demographic data were analysed using t tests and non-continuous variables such as nursing analgesic ratings and patient symptoms using Fisher's Exact test. Comparison of non parametric data such as pain scores and pethidine usage were performed with the Wilcoxon Rank Sum test and Log Rank test. A P value of less than 0.05 was considered statistically significant for all tests.
RESULTS
A total of 56 women were enrolled in this study with 25 subsequently analysed in each data set. Six were withdrawn due to failure to meet operative or anaesthetic protocol. There was no difference between groups with respect to patient characteristics (Table I) .
Analgesia
Although nursing ratings of pain in the recovery room were lower in the indomethacin group, the difference was not significant (rating 'no pain' 28% group I versus 18% group 2, P= 0.29). Similarly, pain scores were lower in the indomethacin group at all assessment times but the differences were not significant. For example, at 30 minutes postoperatively, 54% of those receiving indomethacin compared to 47% of the placebo group had a pain score less than 30 (P = 0.09); and 96% compared to 72% had a score less than 70 (P = 0.07) (Figure 1 ).
Opioid requirements
Groups were similar for the number not requiring any postoperative pethidine (48% vs 32%, group 1 and 2 respectively, P= 0.39). The mean dosage of pethidine used was 24 mg ± 27 mg in the indomethacin group and 42 mg ± 44 mg in the placebo group. This trend to lower requirements in the indomethacin group did not reach statistical significance (P = 0.15). The Wilcoxon Rank Sum test also showed a nonsignificant trend for lower pethidine dose requirements in the indomethacin group, and in the Log Rank test, which places more emphasis on differences at the higher end of the scale, this difference almost reached statistical significance ( Figure 2) .
Pre-and postoperative symptomatology
The incidence of preoperative (postmedication) nausea, headache and abdominal pain did not differ between groups. Although there was a consistently lower incidence of postoperative symptoms or side-effects in those receiving indomethacin, there was no significant difference between groups ( Table 2 ). Wilcoxon Rank Sum test for difference in pethidine use: p = 0.15. Log Rank test for difference in pethidine use: p= 0.07.
DISCUSSION
The use of NSAIDs alone or as an adjunct to opioids in the management of postoperative pain is not new and has been recently reviewed. 2 NSAIDs alone have proven reliable in relieving postoperative pain after minor surgery. Laparoscopic sterilisation is a procedure which is more painful than diagnostic laparoscopy and results in a higher incidence of moderate or severe, but short-lived, postoperative pain.3,4 Prostaglandin production is stimulated by tubal trauma or ischaemia 5 ,6 and prostaglandins, important algogenic substances in the peripheral events after tissue trauma leading to hyperalgesia,2 may play a role in the genesis of pain after laparoscopic sterilisation.
Indomethacin is a widely used NSAID which has been shown to reduce postoperative pain and opioid requirement after major abdominal and Values are percentage orthopaedic surgery.7.1O The intraoperative administration of indomethacin was shown to reduce pain after Falope ring sterilisation 1 but the effect of preoperative administration on postoperative pain and opioid requirements in this setting has not been investigated. Pharmacokinetic profiles indicate that 200 mg of rectal indomethacin two hours preoperatively produces optimum peak plasma concentration, and thus prostaglandin synthetase inhibition, at the time of sterilisation. 1 1 This study has shown that preoperative indomethacin reduces postoperative pain and opioid requirement after laparoscopic sterilisation, as reflected by trends to lower nursing ratings of immediate postoperative pain in the recovery room, lower patient pain scores and lower pethidine requirements. That differences between placebo and treatment groups did not achieve statistical significance probably reflects aB-error and insufficient power. A sample size of 50 in each group would, for example, have been required for a significant result with respect to nursing ratings of pain. A recent clinical trial has confirmed that the preoperative administration of NSAID can reduce the degree of pain reported after laparoscopic sterilisation. 12 The administration of indomethacin 200 mg rectally to fasting, premedicated surgical patients does not appear to cause any side-effects. Although this is the maximum recommended routine daily dose, higher doses have also been employed for short periods without significant side-effects. 7 The potential effect on blood loss secondary to inhibition of platelet aggregation is not a consideration of importance in the clinical setting of this study. Early postoperative morbidity with respect to sequelae such as nausea, shoulder or chest pain, muscle ache and sore throat were not influenced significantly by the administration of indomethacin.
Preoperative NSAIDs appear to reduce pain and opioid requirements after laparoscopic sterilisation and warrant further investigation. The clinical benefits demonstrated in this study were, however, minor, and must be weighed against the disadvantages of patient explanation, including consent for rectal administration, increased nursing workload, especially in busy day surgical units and cost.
